Global Narcolepsy Drugs Market to Register a CAGR of 11.2% as Pandemic Brings Attention to Sleep Disorders
Get a Sample Copy of Narcolepsy Drugs Market: https://www.fairfieldmarketresearch.com/report/narcolepsy-drugs-market/request-sample
Narcolepsy with Cataplexy to Achieves Fastest-Growing Status
According to the Narcolepsy Network, about 70% of patients with narcolepsy experience cataplexy. It manifests in a sudden loss of muscle strength, resulting in slurred speech, jaw-dropping, drooping eyelids, and involuntary twitching amongst others. Cataplexy remains the confirming and conclusive diagnostic measurement of narcolepsy, making narcolepsy with cataplexy or type 1 narcolepsy the fastest-growing segment in the global market. Patients can experience this debilitating condition at a later stage as well. By the end of 2026, type 1 narcolepsy will hold 65% of the global market, predicts Fairfield Market Research.
Sodium Oxybate Remain Undisputed Drug for Treating Narcolepsy
Sodium oxybate is the unrivalled leading drug in the global narcolepsy drugs market. By the end of 2021, this drug is expected to hold a market share of 52% in the global market. This dominance can be attributed to its ability to treat cataplexy and excessive daytime sleepiness (EDS) is expected to bode well for the segment. Furthermore, it is the only drug approved by the US Food and Drug Administration (FDA) for treating cataplexy. Sold under the brand name Xyrem, sodium oxybate is best known to reduce the frequency of sleep attacks in patients with narcolepsy.
Stimulants such as modafinil, amodafonil, antidepressents, and tricuclical are also used in combination to treat narcolepsy. However, sodium oxybate's results remain far better, giving the drug class an edge over others.
Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/narcolepsy-drugs-market/request-customization
North America to Hold Lion's Share in Global Narcolepsy Drugs Market
The National Institute of Neurological Disorders and Stroke, U.S., estimates that about 200,000 people living in the U.S. alone suffer from narcolepsy. Relatively higher awareness about the disorder, access to better healthcare, and increasing expenditure on medical needs are expected to drive the regional market between 2021 and 2026. Fairfield Market Research indicates that North America narcolepsy market will exhibit a CAGR of 11.3% from 2021 to 2025. Europe is expected to follow suit as the region experiences a demographic change that is dictated by information-centric patients.
Meanwhile, sleep disorders brought on by shift-based business models are expected to generate a demand for narcolepsy drugs in Asia Pacific. An overall increase in stress levels is also expected to underpin the growth of Asia Pacific narcolepsy drugs market.
Some of the leading players in the global narcolepsy drugs market are Avadel Pharmaceuticals plc, Harmony Biosciences, Arena Pharmaceuticals, Inc., Axsome Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., GrayMark Healtcare Inc., Ligand Pharmaceuticals, Inc., and Shionogi Inc.
For More Industry Insight Read: https://www.fairfieldmarketresearch.com/report/narcolepsy-drugs-market
Fairfield Market Research
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Follow Us: https://bit.ly/3voYIm9
About Us :-
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values and eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Narcolepsy Drugs Market to Register a CAGR of 11.2% as Pandemic Brings Attention to Sleep Disorders here
News-ID: 2961220 • Views: 837
More Releases from Fairfield market research
Soaring Uptake by Dietary Supplements Industry to Favour Omega 3 Market Growth, …
Global omega 3 market that surpassed the valuation of US$4.4 Bn in the year 2019 is likely to reach the revenue of around US$13 Bn toward the end of 2027. In its latest published report, Fairfield Market Research forecasts a robust 14.6% CAGR for omega 3 market over the period of projection, 2021 - 2027. The growth of fortified foods across international markets and increasing worldwide focus on mother-and-new-born nutrition
Oat Milk Sales Elevate on the Back of Veganism, Dairy-free, Plant-based, and Glu …
Exhibiting an estimated CAGR of 11.5%, global oat milk market value is likely to surpass US$2.6 Bn by the end of 2026. As suggested by the latest Fairfield Market Research report, oat milk sales will gain significantly from the thriving plant-based F&B trend. With plant-based, lactose-free, and gluten-free trend waves gathering momentum over the recent past, the nutrition profile of oat milk will continue to drive its demand at household,
Low Carbon Footprint of Microbial Fuel Cell (MFC) to Create Sustained Demand wit …
The global microbial fuel cell (MFC) market is expected to cross the growth threshold required for competitors to make lucrative gains. The total worth of the global microbial fuel cell (MFC) market is expected to supplant US $15 Mn by the end of 2025, growing at a stupendous CAGR of 9.8% during the period between 2021 and 2025. The wide spectrum of applications pertaining to microbial fuel cells is the
Material Innovations Drive Global Medical Packaging Market; Bags See a Boost ami …
The consistently expanding medical industry, introduction of newer medical treatments and products, and growing overall medical spending of developed, developing, and underdeveloped nations account for the flourishing landscape of medical packaging worldwide. The global spending on medicines was recorded to be over US$1.25 trillion in the year 2020, which had the COVID-19 pandemic as one of the key contributing factors to it. However, the boost has certainly worked to the
More Releases for Narcolepsy
Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques. To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068 Moreover, constant development of
A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Market Trends, outlook and Opportunity Analysis 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime